Summary
M2 EQUITYBITES-June 30, 2011-Valeant Pharmaceuticals licenses North American rights of Elidel and Xerese from Meda
(C)1994-2011 M2 COMMUNICATIONS http://www.m2.comSee the full content of this document
Extract
Xerese From Meda
Specialty pharmaceutical company Valeant Pharmaceutical...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United Kingdom
Explore vLex
For Professionals
For Partners
Company
Other documents:
woman gets first bar ban britain briefing | from the chalkface | On the Couch ; I Don't Want Superman nor a Wimpy Mummy 'S Boy, but Something in Between | clinton set to be secretary of state in obama's dream team | Extreme makeover. | bank of ireland develops new u.k. post office credit card with tsys; u.k. post office is britain's `most shopped' destin... | A Market Report on the German Multiparameter Patient Monitoring Devices Industry: Examine Key M&As, Pipeline Products and the Competitive Landscape. | Tar Heel banking s withdrawal symptoms.
